| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0000038777-22-000101 | Mar 31st, 2022 12:00AM | May 13th, 2022 12:00AM | May 13th, 2022 12:00AM | FRANKLIN RESOURCES INC | 38777 | NEKTAR THERAPEUTICS | COM | 640268108 | 42 | 7780 | SH | DFND | 5 | 3180 | 0 | 4600 | May 14th, 2022 01:14AM | May 14th, 2022 01:14AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0000038777-22-000101 | Mar 31st, 2022 12:00AM | May 13th, 2022 12:00AM | May 13th, 2022 12:00AM | FRANKLIN RESOURCES INC | 38777 | NEKTAR THERAPEUTICS | COM | 640268108 | 15 | 2858 | SH | DFND | 4 | 2858 | 0 | 0 | May 14th, 2022 01:14AM | May 14th, 2022 01:14AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001858789-22-000006 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | YOUSIF CAPITAL MANAGEMENT, LLC | 1858789 | Nektar Therapeutics | COM | 640268108 | 889 | 165007 | SH | SOLE | 10086 | 0 | 154921 | May 13th, 2022 01:33AM | May 13th, 2022 01:33AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001743413-22-000002 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | Principle Wealth Partners LLC | 1743413 | NEKTAR THERAPEUTICS COM | Stock | 640268108 | 81 | 15000 | SH | SOLE | 0 | 0 | 15000 | May 13th, 2022 01:33AM | May 13th, 2022 01:33AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001729300-22-000003 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | X-Square Capital, LLC | 1729300 | NEKTAR THERAPEUTICS | COM | 640268108 | 70 | 13000 | SH | SOLE | 12000 | 0 | 1000 | May 13th, 2022 01:33AM | May 13th, 2022 01:33AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001667731-22-000190 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | Jump Financial, LLC | 1831577 | NEKTAR THERAPEUTICS | Common Stock | 640268108 | 50 | 9268 | SH | SOLE | 1, 2 | 9268 | 0 | 0 | May 13th, 2022 01:32AM | May 13th, 2022 01:32AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001667731-22-000190 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | Jump Financial, LLC | 1831577 | NEKTAR THERAPEUTICS | Common Stock | 640268108 | 131 | 24377 | SH | SOLE | 1 | 24377 | 0 | 0 | May 13th, 2022 01:32AM | May 13th, 2022 01:32AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001628280-22-014046 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | MetLife Investment Management, LLC | 1529735 | NEKTAR THERAPEUTICS | COM | 640268108 | 19 | 3591 | SH | DFND | 1 | 0 | 3591 | 0 | May 13th, 2022 01:32AM | May 13th, 2022 01:32AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001596800-22-000006 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | Connor, Clark & Lunn Investment Management Ltd. | 1596800 | NEKTAR THERAPEUTICS | COM | 640268108 | 908 | 168477 | SH | SOLE | 1 | 168477 | 0 | 0 | May 13th, 2022 01:32AM | May 13th, 2022 01:32AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:nktr | nasdaq:nktr Shareholders | 13F-HR | 0001533421-22-000004 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | Tower Research Capital LLC (TRC) | 1533421 | NEKTAR THERAPEUTICS | COM | 640268108 | 11 | 2040 | SH | DFND | 2 | 2040 | 0 | 0 | May 13th, 2022 01:30AM | May 13th, 2022 01:30AM | Nektar Therapeutics | Health Care | Pharmaceuticals & Biotechnology |